Zhengye Biotechnology Holdings/$ZYBT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Zhengye Biotechnology Holdings
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry and other vaccines.
Ticker
$ZYBT
Sector
Primary listing
Employees
269
Headquarters
Website
ZYBT Metrics
BasicAdvanced
$40m
-
-$0.22
-
-
Price and volume
Market cap
$40m
52-week high
$13.08
52-week low
$0.68
Average daily volume
141k
Financial strength
Current ratio
1.141
Quick ratio
0.584
Long term debt to equity
2.992
Total debt to equity
24.48
Interest coverage (TTM)
-20.74%
Profitability
EBITDA (TTM)
-6.603
Gross margin (TTM)
20.51%
Net profit margin (TTM)
-59.97%
Operating margin (TTM)
-60.59%
Effective tax rate (TTM)
-15.44%
Revenue per employee (TTM)
$63,630
Management effectiveness
Return on assets (TTM)
-9.48%
Return on equity (TTM)
-25.17%
Valuation
Price to revenue (TTM)
2.319
Price to book
0.16
Price to tangible book (TTM)
0.2
Price to free cash flow (TTM)
383.829
Free cash flow yield (TTM)
0.26%
Free cash flow per share (TTM)
0.002
Growth
Revenue change (TTM)
-37.56%
Earnings per share change (TTM)
-694.50%
3-year revenue growth (CAGR)
-23.54%
3-year earnings per share growth (CAGR)
12.89%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs